The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders

Harvard Review of Psychiatry

Volumn 17, Issue 4, 2009, Pages 254-267

  Dakwar, Elias ^a   Levin, Frances R ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Buddhist meditation; Meditation; Mindfulness; Psychiatry; Substance use disorders; Transcendental meditation

Indexed keywords

ALTERNATIVE MEDICINE; ATTENTION; BUDDHIST MEDITATION; CLINICAL TRIAL; COGNITIVE THERAPY; EVIDENCE BASED PRACTICE; HUMAN; MEDITATION; MENTAL DISEASE; METHODOLOGY; MINDFULNESS BASED MEDITATION; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; REVIEW; SUBSTANCE ABUSE; TRANSCENDENTAL MEDITATION;

ATTITUDE TO HEALTH; COGNITIVE THERAPY; HOLISTIC HEALTH; HUMANS; INTERNAL-EXTERNAL CONTROL; MEDITATION; MIND-BODY RELATIONS (METAPHYSICS); SELF CARE; SUBSTANCE-RELATED DISORDERS;

EID: 68649092231     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1080/10673220903149135     Document Type: Review

References (101)

1. Ludwig DS, Kabat-Zinn J. Mindfulness in medicine. JAMA 2008;300:1350-1352
2. Ader R. Much ado about nothing. Adv Mind Body Med 2001;17:293-295
3. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens 2008;21:310-316 (Pubitemid 351323278)
4. Schneider RH, Walton KG, Salerno JW, Nidich SI. Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care. Ethn Dis 2006;16(3 suppl 4):S4-15-26.
5. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. J Psychosom Res 2004;57:35-43.
6. Smith JE, Richardson J, Hoffman C, Pilkington K. Mindfulness-based stress reduction as supportive therapy in cancer care: systematic review. J Adv Nurs 2005;52:315-327 (Pubitemid 41475412)
7. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 2006;166:1218-1224 (Pubitemid 43877632)
8. Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging 2007;28:1623-1627 (Pubitemid 47238540)
9. Wolf DB, Abell N. Examining the effects of meditation techniques on psychosocial functioning. Res Soc Work Pract 2003;13:27-42. (Pubitemid 36092903)
10. Shannahoff-Khalsa DS. Kundalini Yoga meditation techniques for the treatment of obsessive-compulsive and OC spectrum disorders. Brief Crisis Interv 2003;3:369-382
11. Aron A, Aron EN. The transcendental meditation program's effect on addictive behavior. Addict Behav 1980;5:3-12. (Pubitemid 10013349)
12. Marlatt GA, Marques JK. Meditation, self-control and alcohol use. In: Stuart RB, ed. Behavioral self-management: strategies, techniques and outcome. New York: Brunner/Mazel, 1977:117-153
13. Linehan MM, Comtois KA, Murray AM, et al. Two year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006;62:1-10.
14. Cahn BR, Polich J. Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychol Bull 2006;132:180-211.
15. Walsh R, Shapiro SL. The meeting of meditative disciplines and Western psychology: a mutually enriching dialogue. Am Psychol 2006;61:227-239
16. Craven JL. Meditation and psychotherapy. Can J Psychiatry 1989;34:648-653
17. Young JD, Taylor E. Meditation as a voluntary hypometabolic state of biological activation. News Physiol Sci 1998;13:149-153 (Pubitemid 128090432)
18. University of Alberta Evidence-Based Practice Center. Meditation practices for state of the health [Agency for Healthcare Research and Quality publication no. 07-E010]. 2007. http://www.ahrq.gov/downloads/pub/evidence/pdf/ meditation/medit.pdf
19. Hankey A. Studies of advanced stages of meditation in the Tibetan Buddhist and Vedic traditions. I: a comparison of general changes. Evid Based Complement Alternat Med 2006;3:513-521
20. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain and illness. New York: Delacorte, 2000.
21. Cardoso R, de Souza E, Camano L, Leite Jr. Meditation in health: an operational definition. Brain Res Brain Res Protoc 2004;14:58-60.
22. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982;4:33-47. (Pubitemid 12088404)
23. Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract 2003;10:125-143
24. Lazar SW, Rosman IS, Vanget M, et al. Functional brain imaging of mindfulness and mantra-based meditation. Paper presented at the meeting of the Society for Neuroscience, New Orleans, LA, November 2003.
25. Valentine ER, Sweet PLG. Meditation and attention: a comparison of the effects of concentrative and mindfulness meditation on sustained attention. Ment Health Relig Cult 1999;2:59-70.
26. Kabat-Zinn J. Indra's net at work: the mainstreaming of Dharma practice in society. In: Watson G, Batchelor S, eds. The psychology of awakening: Buddhism, science and our day-to-day lives. 2000. North Beach,ME:Weiser, 2000:225-249
27. Yogi M. The science of being and art of living. New York: Penguin, 1963.
28. Pueschel M. Vedic medicine, meditation receive federal funds. US Med 2000;July. http://www.usmedicine.com/article.cfm?articleID=47&issueID=12
29. TM effective in reducing high blood pressure, study show. U Kentucky News 2007;Dec 5. http://news.uky.edu/news/display article.php?artid=2963
30. http://www.tm.org
31. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol 1971;221:795-799
32. Wallace RK. Physiological effects of transcendental meditation. Science 1970;167:1751-1754
33. Wallace RK. The physiology of meditation. Sci Am 1972;226:84-90.
34. Dillbeck MC, Bronson EC. Short-term longitudinal effects of the transcendental meditation technique on EEG power and coherence. Int J Neurosci 1981;14:147-151
35. Hebert R, Tan G. Enhanced EEG alpha phase synchrony in practitioners of the transcendental meditation technique. Paper presented at the meeting of the International Society for Neuronal Regulation, Winterthur, Switzerland, April 2004.
36. Travis F, Tecce J, Arenander A, Wallace RK. Patterns of EEG coherence, power, and contingent negative variation characterize the integration of transcendental and waking states. Biol Psychol 2002;61:293-319. (Pubitemid 36163414)
37. Basar E, Schurmann M, Basar-Eroglu C, Karakas S. Alpha oscillations in brain functioning: an integrative theory. Int J Psychophysiol 1997;26:5-29. (Pubitemid 27277683)
38. Basar E, Basar-Eroglu C, Karakas S, Schurmann M. Gamma, alpha, delta, and theta oscillations govern cognitive processes. Int J Psychophysiol 2001; 39:241-248 (Pubitemid 32041270)
39. Streeter CC, Jensen JE, Perlmutter RM, et al. Yoga Asana sessions increase brain GABA levels: a pilot study. J Altern Complment Med 2007;13:419-426
40. Elias AN, Guich S, Wilson AF, et al. Ketosis with enhanced GABAergic tone promotes physiological changes in transcendental meditation. Med Hypotheses 2000;54: 660-662 (Pubitemid 30311566)
41. Jevning R, Anand R, Biedebach M, Fernando G. Effects on regional cerebral blood flow of transcendental meditation. Physiol Behav 1996;59:399-402. (Pubitemid 26084097)
42. Maclean CR, Walton KG, Wenneberg SR, et al. Effects of the transcendental meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology 1997;22: 277-295
43. Alexander CN, Langer EJ, Newman RI, Chandler HM, Davies JL, et al. Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly. J Pers Soc Psychol 1989;57:950-964
44. Wolf DB, Abell N. Examining the effects of meditation techniques on psychosocial functioning. Res Soc Work Pract 2003;13:27-42. (Pubitemid 36092903)
45. Raskin M, Bali LR, Peeke HV. Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety. Arch Gen Psychiatry 1980;37:93-97
46. Canter PH, Ernst E. The cumulative effects of Transcendental Meditation on cognitive function - a systematic review of randomised controlled trials. Wien Klin Wochenschr 2003;115:758-766 (Pubitemid 38111140)
47. de Bary WT. The Buddhist tradition in India, China and Japan. New York: Vintage, 1972.
48. Ford J. Zen Master Who? A guide to the people and stories of Zen. Somerville, MA: Wisdom, 2006.
49. Echenhofer FG, Coombs MM, Samten L. EEG and P300 differences during meditation and rest in advanced Tibetan Buddhist and beginning meditators. Paper presented at the meeting of the Society for Psychophysical Research, San Diego, CA, October 1992.
50. Faber PL, Lehmann D, Gianotti LRR, Kaelin M, Pascual-Marqui RD. Scalp and intracerebral (LORETA) theta and gamma EEG coherence in meditation. Paper presented at the meeting of the International Society for Neuronal Regulation, Winterthur, Switzerland, April 2004.
51. Dunn BR, Hartigan JA, Mikulas WL. Concentration and mindfulness meditations: unique forms of consciousness? Appl Psychophysiol Biofeedback 1999;24:147-165
52. Ritskes R, Ritskes-Hoitinga M, Stodkilde-Jorgensen H, Baerentsen K, Hartman T. MRI scanning during Zen meditation: the picture of enlightenment? Constructivism Hum Sci 2003;8:85-90.
53. Newberg A, Pourdehnad M, Alavi A, d'Aquili EG. Cerebral blood flow during meditative prayer: preliminary findings and methodological issues. Percept Motor Skills 2003;97:625-630
54. Baerentsen KB. Onset of meditation explored with fMRI. Neuroimage 2001;13:S297.
55. Murata T, Takahashi T, Hamada T, et al. Individual trait anxiety levels characterizing the properties of Zen meditation. Neuropsychobiology 2004;50:189-194 (Pubitemid 39077841)
56. Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. Neuroreport 2005;16:1893-1897
57. Khalsa SS, Rudrauf D, Damasio AR, Davidson RJ, Lutz A, Tranel D. Interoceptive awareness in experienced meditators. Psychophysiology 2008;45:671-677
58. Pagnoni G, Cekic M, Guo Y. 'Thinking about not-thinking': neural correlates of conceptual processing during Zen meditation. PLoS ONE 2008;3:e3083.
59. Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging 2007;28:1623-1627 (Pubitemid 47238540)
60. Pace TW, Negi LT, Adame DD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 2009;34:87-98.
61. Brefczynski-Lewis JA, Lutz A, Schaefer HS, Levinson DB, Davidson RJ. Neural correlates of attentional expertise in long-term meditation practitioners. Proc Natl Acad Sci U S A 2007;104:11483-11488 (Pubitemid 47175166)
62. Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Database Syst Rev 2006;(1):CD004998.
63. Disayavanish P. The effect of Buddhist insight meditation on stress and anxiety [PhD dissertation]. Illinois State University, Department of Educational Administration and Foundations, 1994.
64. Bowen S, Witkiewitz K, Dillworth TM, et al. Mindfulness meditation and substance use in an incarcerated population. Psychol Addict Behav 2006;20:343-347 (Pubitemid 44386434)
65. Marlatt GA, Kristeller J. Mindfulness and meditation. In: Miller WR, ed. Integrating spirituality into treatment. Washington, DC: American Psychological Association, 1999:67-84.
66. Kabat-Zinn, J. Wherever you go, there you are: mindfulness meditation in everyday life. New York: Hyperion, 1994.
67. Hanh TN. The miracle of mindfulness. Boston: Beacon, 1976.
68. Hayes SC, Wilson KG. Some applied implications of a contemporary analytic account of verbal events. Behavior Anal 1993;16:283-301.
69. Hayes SC. Acceptance and change: content and context in psychotherapy. Reno, NV: Context, 1994.
70. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982;4:33-47. (Pubitemid 12088404)
71. Linehan MM. Skills training manual for treating borderline personality disorder. New York: Guilford, 1993.
72. Teasdale JD, Segal Z, Williams JM. How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness training) help? Behav Res Ther 1995;33:25-39.
73. Kristeller JL, Hallett CB. An exploratory study of a meditation-based intervention for binge eating disorder. J Health Psychol 1999;4:357-363
74. Farb, Segal ZV, Mayberg H. Attending to the present: mindfulness meditation reveals distinct neural modes of self-reference. Soc Cogn Affect Neurosci 2007;2:313-322 (Pubitemid 350186993)
75. Baron Short E, Kose S, Mu Q, et al. Regional brain activation during meditation shows time and practice effects: an exploratory fMRI study. Evid Based Complement Alternat Med 2007;Oct 27 [Epub ahead of print].
76. Ramel W, Goldin PR, Carmona PE, McQuaid JR. The effects of mindfulness meditation on cognitive process and affect in patients with past depression. Cognit Ther Res 2004;28:433-455 (Pubitemid 40655400)
77. Tacon AM, McComb J, Caldera Y, Randolph P. Mindfulness meditation, anxiety reduction, and heart disease: a pilot study. Fam Community Health 2003;26:25-33.
78. Oman D, Shapiro SL, Thoresen CE, Plante TG, Flinders T. Meditation lowers stress and supports forgiveness among college students: a randomized controlled trial. J Am Coll Health 2008;56:569-578
79. Sephton S, Salmon P, Weissbecker I, et al. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Rheum 2007;57:77-85. (Pubitemid 46256728)
80. Lynch TR, Trost WT, Salsman N, Linehan MM. Dialectical behavior therapy for borderline personality disorder. Annu Rev Clin Psychol 2007;3:181-205. (Pubitemid 46651126)
81. Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract 2008;4:39-47.
82. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000;68:615-623 (Pubitemid 30747205)
83. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 2004;72: 31-40.
84. Williams JM, Teasdale JD, Segal ZV, Soulsby J. Mindfulness-based cognitive therapy reduces overgeneral autobiographical memory in formerly depressed patients. J Abnorm Psychol 2000;109:150-155 (Pubitemid 30155417)
85. Hoppes K. The application of mindfulness-based cognitive interventions in the treatment of co-occurring addictive and mood disorders. CNS Spectr 2006;11:829-851 (Pubitemid 44845662)
86. Castillo RJ. Depersonalization and meditation. Psychiatry 1990;53:158-168
87. Lazarus AA. Psychiatric problems precipitated by transcendental meditation. Psychol Rep 1976;39:601-602
88. Walsh R, Roche L. Precipitation of acute psychotic episodes by intensive meditation in individuals with a history of schizophrenia. Am J Psychiatry 1979;136:1085-1086 (Pubitemid 9221662)
89. Chan-Ob T, Boonyanaruthee V. Meditation in association with psychosis. J Med Assoc Thai 1999;82:925-930
90. Singh NN, Lancioni GE, Winton AS, et al. Individuals with mental illness can control their aggressive behavior through mindfulness training. Behav Modif 2007;31:313-328
91. Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Safety, tolerability and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 2006;67:1735-1740 (Pubitemid 44955154)
92. Krupitsky EM, Burakov AM, Dunaevsky IV, Romanova TN, Slavina TY, Grinenko AY. Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. J Psychoactive Drugs 2007;39:13-19
93. Ellison CG, Levin JS. The religion-health connection: evidence, theory and future directions. Health Educ Behav 1998;25:700-720 (Pubitemid 128460458)
94. Flynn PM, Joe GW, Broome KM. Looking back on cocaine dependence: reasons for recovery. Am J Addict 2003;12:398-411.
95. Koenig HG, McCullough ME, Larson DB. Handbook of religion and health. Oxford: Oxford University Press, 2001.
96. Miller WR. Researching the spiritual dimensions of alcohol and other drug problems. Addiction 1998;93:979-990
97. Miller WR, C'de Baca J. Quantum change: when epiphanies and sudden insights transform ordinary lives. New York: Guilford, 2001.
98. Emmons RA. The psychology of ultimate concerns: motivation and spirituality in personality. New York: Guilford, 1999.
99. Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 2006;187:268-283 (Pubitemid 44088380)
100. Marlatt GA, Witkiewitz K, Dillworth TM, et al. Vipassana meditation as a treatment for alcohol and drug use disorders. In: Hayes SC, Follette VM, Linehan MM, eds. Mindfulness and acceptance: expanding the cognitive-behavioral tradition. New York: Guilford, 2004:261-287
101. Marlatt GA, Donovan DM. Relapse prevention. 2nd ed. New York: Guilford, 2000.